finance of america

Myopia, aka nearsightedness, is extremely common and can start in childhood or young adults. Over time it can lead to early-onset cataracts, retinal detachment, and glaucoma. MedPageToday has an eye-opening article on treatments that can prevent myopia progression and complications. For example:

Common evidence-based treatments that offer both statistically significant and clinically meaningful efficacy include daytime multifocal soft contact lenses (MFSCL), overnight orthokeratology (ortho-k), and topical low dose atropine (LDA). Novel spectacle lenses also showed a promising myopia-inhibiting effect, although with limited availability in the US at the